← Every company
Daiichi Sankyo Co Ltd Lobbying
What Daiichi Sankyo Co Ltd discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
DSNKY on carbonthat →Disclosed spend
$830K
across every filing on file
Filings
11
Years covered
1
Firms retained
4
What it lobbies about
PharmacyTrade (domestic/foreign)Health IssuesMedicare/MedicaidTaxation/Internal Revenue CodeCopyright/Patent/Trademark
11 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | DAIICHI SANKYO, INC.Health IssuesTaxation/Internal Revenue Code | $380K |
| 20261st Quarter (Jan 1 - Mar 31) | DAIICHI SANKYO, INC.Health IssuesTaxation/Internal Revenue Code | $130K |
| 20262nd Quarter (Apr 1 - June 30) | MARSHALL & POPP, LLCPharmacyTrade (domestic/foreign) | $60K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK GROUPHealth IssuesMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | FARRAGUT PARTNERS LLPHealth Issues | $50K |
| 20262nd Quarter (Apr 1 - June 30) | FARRAGUT PARTNERS LLPHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCPharmacyTrade (domestic/foreign) | — |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCPharmacy | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.